Literature DB >> 27114397

eComment. Benefits of macrolide usage and bacteriological profile in patients with diffuse panbronchiolitis.

Tomislav Mestrovic1, Marijana Neuberg2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27114397      PMCID： PMC4892168          DOI： 10.1093/icvts/ivw082

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  5 in total

1.  Nontuberculous mycobacteria in diffuse panbronchiolitis.

Authors:  Takahiro Tsuji; Eisaku Tanaka; Ikkoh Yasuda; Yoshinari Nakatsuka; Yusuke Kaji; Takehiro Yasuda; Seishu Hashimoto; Moon Hee Hwang; Takashi Hajiro; Yoshio Taguchi
Journal:  Respirology       Date:  2014-09-30       Impact factor: 6.424

Review 2.  Diffuse panbronchiolitis.

Authors:  V Poletti; G Casoni; M Chilosi; M Zompatori
Journal:  Eur Respir J       Date:  2006-10       Impact factor: 16.671

3.  [Clinical Analysis of 35 Inpatients with Diffuse Panbronchiolitis in Peking Union Medical College Hospital].

Authors:  Li-li Lou; Hai-hong Gong; Ming-qiang Zhang; Jin-ming Gao
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2015-12

Review 4.  Macrolides for diffuse panbronchiolitis.

Authors:  Xiufang Lin; Jing Lu; Ming Yang; Bi Rong Dong; Hong Mei Wu
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

5.  Lung transplantation for diffuse panbronchiolitis: 5 cases from a single centre.

Authors:  Seiichiro Sugimoto; Kentaroh Miyoshi; Masaomi Yamane; Takahiro Oto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.